As summarized by the American Journal of Managed Care: "Physicians have pointed out that no other chronic condition in Medicare is treated this way with an effective medication offered temporarily and then potentially withdrawn." For obesity, which is classified as a chronic condition by the American Medical Association and most major medical societies, offering 18 months of effective treatment with no guaranteed continuation is clinically unusual
The increase of intracellular ROS is believed to correlate with the activation of nuclear factor (NF)-kappa B, a transcription activator linked to the elaboration of several cytokines (Figure 6)
Mice carrying the dominant-negative Clock mutation develop obesity, hypertriglyceridemia, and marked hepatic steatosis driven by persistent activation of SREBP-1cmediated lipogenesis (40)
[DOI] [PMC free article] [PubMed] [Google Scholar] Zhou Y, Tang J, Lan J, Zhang Y, Wang H, Chen Q, Kang Y, Sun Y, Feng X, Wu L, Jin H, Chen S, Peng Y